Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 111 publications
Impact of Prior Chimeric Antigen Receptor T-Cell Treatment on Graft-Versus-Host Disease and Nonrelapse Mortality After Allogeneic Transplantation.
Journal: Transplantation and cellular therapy
Published: May 01, 2026
NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 13, 2026
Efficacy of Splenectomy for Hematologic Malignancies: A Retrospective Cohort Study.
Journal: Annals of surgery
Published: January 28, 2026
The role of MRD monitoring and options for CLL management in relapsed/refractory disease.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 05, 2025
Five-year survival outcomes from TRANSCEND NHL 001 of lisocabtagene maraleucel in R/R LBCL.
Journal: Blood
Published: November 05, 2025
Copanlisib in combination with venetoclax in patients with relapsed/refractory mantle cell lymphoma.
Copanlisib in combination with venetoclax in patients with relapsed/refractory mantle cell lymphoma.
Journal: Leukemia & lymphoma
Published: October 31, 2025
Humoral and functional SARS-CoV-2-specific T-cell responses elicited in chronic lymphocytic leukaemia patients with GEO-CM04S1 a synthetic MVA-vectored COVID-19 vaccine.
Journal: British journal of haematology
Published: September 23, 2025
Immunotherapy in Chronic Lymphocytic Leukemia.
Journal: Hematology/oncology clinics of North America
Published: July 09, 2025
Clinical Practice Recommendations on the Role Of Allogeneic Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Patients With Chronic Lymphocytic Leukemia on Behalf of the American Society for Transplantation and Cellular Therapy.
Journal: Transplantation and cellular therapy
Published: May 30, 2025
Last Updated: 09/26/2026